ea0090p809 | Late-Breaking | ECE2023
Raia Salvatore
, Chiloiro Sabrina
, Grazia Maratta Maria
, Maiorano Brigida
, Rossi Ernesto
, Gabriella Brizi Maria
, Rufini Vittoria
, De Marinis Laura
, Pontecorvi Alfredo
, Tortora Giampaolo
, Rindi Guido
, Schinzari Giovanni
, Bianchi Antonio
Introduction: Non-functioning (NF), sporadic and MEN1 associated, G1-G2 pancreatic neuroendocrine tumors (PanNETs) usually display an indolent course. Surgery is the first-choice treatment for localized tumors >2 cm. Unresectable or metastatic PanNETs expressing somatostatin receptors (SSTRs) are treated with somatostatin analogs (SSAs). The standard treatment for patients with PanNETs ≤ 2 cm is active surveillance (AS). Yet no evidence of the value of SSA treatment ...